0.5800
-0.0100
(-1.69%)
At close: January 31 at 5:35:06 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
16,632.3490
18,369.6720
8,372.1340
12,409.2600
Total Liabilities Net Minority Interest
12,941.6490
6,588.2960
4,172.0930
5,439.8790
Total Equity Gross Minority Interest
3,690.7000
11,781.3760
4,200.0410
6,969.3810
Total Capitalization
12,517.3600
14,384.9370
7,106.7840
10,099.6170
Common Stock Equity
3,690.7000
11,781.3760
4,200.0410
6,969.3810
Net Tangible Assets
2,543.6320
10,986.9100
3,580.6750
6,177.4270
Working Capital
10,290.1230
12,445.9930
5,317.7330
9,092.4260
Invested Capital
12,517.3600
14,384.9370
7,106.7840
10,099.6170
Tangible Book Value
2,543.6320
10,986.9100
3,580.6750
6,177.4270
Total Debt
8,826.6600
2,603.5610
2,906.7430
3,130.2360
Net Debt
8,504.0800
--
--
--
Share Issued
16,679.5140
16,607.5140
6,851.4170
6,851.4170
Ordinary Shares Number
16,634.9260
16,590.9920
6,851.4170
6,851.4170
Treasury Shares Number
44.5880
16.5220
--
--
12/31/2020 - 10/5/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GXE.BE Galapagos NV
22.30
+0.54%
ALGEN.PA genOway Société anonyme
3.4600
+1.76%
TNG.PA Transgene SA
0.6930
-4.55%
ALCLS.PA Cellectis S.A.
1.5400
+1.45%
IPH.PA Innate Pharma S.A.
1.8000
+3.09%
GNFT.PA Genfit S.A.
3.5750
-2.85%
VLA.PA Valneva SE
2.7280
+10.89%
ANVS Annovis Bio, Inc.
4.8700
-0.41%
ETNB 89bio, Inc.
9.60
-0.41%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%